Sign up to receive updates about new posts on this collaborative blog.
Pathology remains to be one of the last few practices of medicine that is only just recently beginning to evolve into a digital...
Topics: pathology, digital pathology, business case,
The astonishing success of artificial intelligence (AI) over the past few years in solving complex recognition problems has...
Topics: pathology, digital pathology, ai,
The human impact of delaying the cancer patient's journey
Catching cancer early saves lives. This is the adage that at-risk...
Topics: pathology, digital pathology, business case,
Before the pandemic, our focus was to support the formation and delivery of pathology networks across NHS England as part of the ...
“It takes humility to seek feedback. It takes wisdom to understand it, analyze it, and appropriately act on it.”
--- Stephen...
Topics: Post-COVID-19, pathology, digital pathology,
"Innovation comes ultimately from a diversity of perspectives."
--- Frans Johansson
Inspirata welcomed subject matter experts...
Topics: Post-COVID-19, pathology, digital pathology,
According to MIT, 90% of information transmitted to the human brain is visual, with humans being able to identify images seen for...
Topics: Post-COVID-19, pathology, digital pathology,
Critical Question Facing Pathologists: Will There Be Enough Capacity to Serve the Backlog of Cases When Normal Scheduling Resumes?
Topics: Post-COVID-19, backlog, pathology
Originally streamed on October 5th, 2021; This virtual event brought together three key members of the Inspirata team, to discuss how Dynamyx, E-Path, and Trial Navigator can help healthcare institutions to achieve insights that scale across the entire oncology organization.
Watch On-Demand